Table 3 HIV epitopes with homology to TuAs derived from cancer-specific proteins
From: Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case
Breast CA—CCR9 | ||||||
|---|---|---|---|---|---|---|
HLA | TAA | HIV | ||||
PEPTIDE | AFF (nM) | PEPTIDE | AFF (nM) | Protein | GeneBank CODE | |
HLA-A*02:01 | AIADLLFLV | 3,76 | RLRDLLFLV | 10,01 | env | AEN20914.1 |
HLA-B*58:01 | LGCISQAQW | 22,22 | YCNISQAQW | 30,01 | env | QBF53490.1 |
HCNISEAQW | 66,16 | env | AFE02648.1 | |||
HCNISQTQW | 61,58 | env | QGJ15916.1 | |||
HLA-B*58:01 | NSLVILVYW | 28,08 | ASLVIITYW | 11,65 | vif | AAW57764.1 |
HLA-A*24:02 | CYTIIIHTL | 40,22 | NYTEIIHTL | 43,35 | env | AAX97247.1 |
Brain CA—DPYSL2 | ||||||
|---|---|---|---|---|---|---|
HLA | TAA | HIV | ||||
PEPTIDE | AFF (nM) | PEPTIDE | AFF (nM) | Protein | GeneBank CODE | |
HLA-B*07:02 | IPRRTTQRI | 19,79 | IPRRIRQRI | 25,38 | env | AET80771.1 |
Colon CA—CEACAM8 | ||||||
|---|---|---|---|---|---|---|
HLA | TAA | HIV | ||||
PEPTIDE | AFF (nM) | PEPTIDE | AFF (nM) | Protein | GeneBank CODE | |
HLA-B*15:01 | IQNPASANF* | 9,34 | RQGPASSNF | 20,55 | pol | QIC94847.1 |
HLA-B*58:01 | YSWSVNGTF | 20,84 | SSWNVNGTW | 5,6 | env | ANO43474.1 |
HLA-A*03:01 | GTFQQYTQK* | 35,5 | RTFQQYKKK | 42 | env | ABA08367.1 |
HLA-B*15:01 | VTRNDTGSY | 94,41 | VTRNDTSTY | 71,3 | env | AAO20547.1 |
Colon CA—GLOD5 | ||||||
|---|---|---|---|---|---|---|
HLA | TAA | HIV | ||||
PEPTIDE | AFF (nM) | PEPTIDE | AFF (nM) | Protein | GeneBank CODE | |
HLA-A*03:01 | KMWGRTLEK | 3,88 | TQWGRTLEK | 90,05 | env | ACD34677.1 |
Colon CA—EPCAM | ||||||
|---|---|---|---|---|---|---|
HLA | TAA | HIV | ||||
PEPTIDE | AFF (nM) | PEPTIDE | AFF (nM) | Protein | GeneBank CODE | |
HLA-B*58:01 | CSERVRTYW | 23,26 | VSERLKTYW | 20,72 | env | AAO20591.1 |
HLA-A*02:01 | VVAGIVVLV | 48,75 | VVAGIIALV | 24,48 | vpu | AUO72667.1 |
VIAGIVALV | 17,96 | vpu | ABI50903.1 | |||
VVASIVALV | 36,96 | vpu | QGU21448.1 | |||
HLA-B*40:01 | AEIKEMGEM | 66,18 | AELGEMGEM | 87,18 | vpu | AEW28038.1 |
HLA-B*39:01 | THSPNSRAV | 81,49 | THSPSSREL | 51,06 | pol | AMX26992.1 |
Lung CA—PRPF40A | ||||||
|---|---|---|---|---|---|---|
HLA | TAA | HIV | ||||
PEPTIDE | AFF (nM) | PEPTIDE | AFF (nM) | Protein | GeneBank CODE | |
HLA-B*08:01 | QLRKRNWEA | 57,55 | LLRRRGWEA | 22,01 | env | ACE65673.1 |
VLRRRGWEA | 43,08 | env | AXP17656.1 | |||
TLRRRGWEA | 27,86 | env | QMX89949.1 | |||
ILRRRGWEA | 35,96 | env | QPK37756.1 | |||
Lung CA—CNIH4 | ||||||
|---|---|---|---|---|---|---|
HLA | TAA | HIV | ||||
PEPTIDE | AFF (nM) | PEPTIDE | AFF (nM) | Protein | GeneBank CODE | |
HLA-B*58:01 | LLNLPVATW | 99,66 | HCNLSVATW | 38,73 | env | ACR83664.1 |
Prostate CA—NDUFS2 | ||||||
|---|---|---|---|---|---|---|
HLA | TAA | HIV | ||||
PEPTIDE | AFF (nM) | PEPTIDE | AFF (nM) | Protein | GeneBank CODE | |
HLA-A*01:01 | VSDGSSRPY | 72,62 | SSDNSSRPY | 60,07 | env | ANC69009.1 |
GSDSTSRPY | 99,17 | env | AFV81777.1 | |||